Loading organizations...
Key people at Delphinus Venture Capital.
Delphinus Venture Capital is a Danish firm investing in research-driven deep-tech startups, transforming academic innovation into commercial impact. It operates an evergreen fund, supporting companies from pre-seed to growth stages with long-term partnerships. The firm targets sectors like Food & Agriculture, Health & Longevity, Defense & Security, and Energy & Bioeconomy.
Established in 2025 by Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group, Mathias Brink Lorenz directs the fund. Its foundation stems from the insight that commercializing research-based ventures demands significant time, courage, and sustained capital, bridging the gap between scientific discovery and market.
The firm serves founders of Danish deep-tech startups dedicated to solving real-world problems. It seeks teams skilled in technical development and commercialization. Delphinus Venture Capital's vision is to be a consistent partner from lab to market, fostering new research-based innovation to create global impact.
Key people at Delphinus Venture Capital.
Delphinus Venture Capital has 1 tracked investment across 1 company. The latest tracked deal is $339.0M Seed in MedicQuant in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 19, 2026 | MedicQuant | $339.0M Seed | Delphinus Venture Capital | EIFO |